Pear Therapeutics, Inc. Quarterly Debt-to-equity in % from Q3 2021 to Q4 2022

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Pear Therapeutics, Inc. quarterly Debt-to-equity history and growth rate from Q3 2021 to Q4 2022.
  • Pear Therapeutics, Inc. Debt-to-equity for the quarter ending December 31, 2022 was 129 %, a 77.6% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q4 2022 129 +56.3 +77.6% Dec 31, 2022
Q3 2022 117 +67.1 +135% Sep 30, 2022
Q2 2022 112 Jun 30, 2022
Q1 2022 109 Mar 31, 2022
Q4 2021 72.6 Dec 31, 2021
Q3 2021 49.7 Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.